Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 19, 2022
One-month DAPT after acute coronary syndrome: too short or not too short?Piera Capranzano
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[Direct oral anticoagulants for patients with atrial fibrillation undergoing transcatheter aortic valve implantation: novel evidence from the ENVISAGE-TAVI AF trial]Piera Capranzano
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 6, 2019
The sunset of triple antithrombotic therapy for atrial fibrillation patientsPiera Capranzano
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
The stent in the high-bleeding risk patient: antiplatelet monotherapy?Piera Capranzano
Circulation. Cardiovascular Interventions|June 17, 2016
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of ChoiceCorrado Tamburino, Piera Capranzano
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 3, 2021
Timing of cardioversion in atrial fibrillation: the sooner the better?Piera Capranzano, Valeria Calvi
Giornale Italiano Di Cardiologia (2006)|July 8, 2016
[Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: the quest for the Holy Grail]Piera Capranzano, Davide Capodanno
Giornale Italiano Di Cardiologia (2006)|December 7, 2018
[Coronary artery disease: when to withhold a decision and call in the Heart Team? Almost never]Piera Capranzano, Corrado Tamburino
Vascular Pharmacology|March 17, 2019
Switching between P2Y<sub>12</sub> inhibitors: Rationale, methods, and expected consequencesPiera Capranzano, Davide Capodanno
Current Cardiology Reports|July 4, 2012
Late stent thrombosis: the last remaining obstacle in coronary interventional therapyPiera Capranzano, George Dangas
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 19, 2022
One-month DAPT after acute coronary syndrome: too short or not too short?Piera Capranzano
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[Direct oral anticoagulants for patients with atrial fibrillation undergoing transcatheter aortic valve implantation: novel evidence from the ENVISAGE-TAVI AF trial]Piera Capranzano
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 6, 2019
The sunset of triple antithrombotic therapy for atrial fibrillation patientsPiera Capranzano
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
The stent in the high-bleeding risk patient: antiplatelet monotherapy?Piera Capranzano
Circulation. Cardiovascular Interventions|June 17, 2016
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of ChoiceCorrado Tamburino, Piera Capranzano
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 3, 2021
Timing of cardioversion in atrial fibrillation: the sooner the better?Piera Capranzano, Valeria Calvi
Giornale Italiano Di Cardiologia (2006)|July 8, 2016
[Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: the quest for the Holy Grail]Piera Capranzano, Davide Capodanno
Giornale Italiano Di Cardiologia (2006)|December 7, 2018
[Coronary artery disease: when to withhold a decision and call in the Heart Team? Almost never]Piera Capranzano, Corrado Tamburino
Vascular Pharmacology|March 17, 2019
Switching between P2Y<sub>12</sub> inhibitors: Rationale, methods, and expected consequencesPiera Capranzano, Davide Capodanno
Current Cardiology Reports|July 4, 2012
Late stent thrombosis: the last remaining obstacle in coronary interventional therapyPiera Capranzano, George Dangas
Pageof 23